-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Upgrades PTC Therapeutics to Buy, Raises Price Target to $68

Benzinga·05/09/2025 13:12:10
Listen to the news
B of A Securities analyst Tazeen Ahmad upgrades PTC Therapeutics (NASDAQ:PTCT) from Neutral to Buy and raises the price target from $55 to $68.